ACSS2 and pancreatic ductal adenocarcinoma: ACSS2 is up-regulated in human pancreatic ductal adenocarcinoma cell lines, and shRNA knockdown of ACSS2 inhibits cancer cell death while increasing cell cloning and the decreasing of intracellular pH, indicating that it is an active regulator for the pancreatic ductal adenocarcinoma treatment [100].